Sun Pharma receives US FDA approval for drug to treat alopecia areata

Quick Summary:

In two Phase-III clinical trials, patients initially had an average of only 13 per cent scalp hair coverage.

Marek Honczarenko, MD, PhD, senior vice president and head of development at Sun Pharma, expressed satisfaction with the FDA's timely approval."This approval validates our team's capability to bring treatments from research and development to approval in a meaningful way for physicians and patients," he said.

Food and Drug Administration (FDA) approval for LEQSELVI (deuruxolitinib) for the treatment of severe alopecia areata in adults.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaMaliUnited States

Topics: Sun Pharma Pharma industry Indian drug makers USFDA US drug companies US drug approvals

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-26 @ 11:28:22 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 590 words

Reading Time: 4 minutes read

Sentences: 21 lines

Sentence Length: 29 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 21781104

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 237 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions